Edition:
United Kingdom

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

88.00SEK
15 Dec 2017
Change (% chg)

-0.50kr (-0.56%)
Prev Close
88.50kr
Open
88.50kr
Day's High
89.50kr
Day's Low
86.00kr
Volume
44,778
Avg. Vol
43,766
52-wk High
96.00kr
52-wk Low
41.10kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.296
Jun '17 0.00 -1.690
Mar '17 0.00 -1.599
FY 2016 Dec '16 0.00 -2.067
Sep '16 0.00 -1.060
Jun '16 0.00 -1.190
Mar '16 0.00 -0.920
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Dec-17 2 -6.09 -6.05 -6.12 --
Year Ending Dec-18 2 -6.72 -6.21 -7.24 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) -- 100.68 5.40
Price to Book (MRQ) 4.74 13.50 5.38
Price to Tangible Book (MRQ) 4.74 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions -- 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -41.99 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 9.54 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -261.13 15.24
Operating Margin (TTM) -- -556.69 7.76
Operating Margin - 5 Yr. Avg. -- -279.31 10.75
Pre-Tax Margin (TTM) -- -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.05 11.17
Net Profit Margin (TTM) -- -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,316,769 864,680,397
Net Income/Employee (TTM) -22,784,650 3,332,346 101,718,341
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.00 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.83 -0.77 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -76.13 2.36 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -76.18 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -114.56 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oncopeptides AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.17 -- 80 53
13 Week -1.17 -- 99 60
26 Week 43.67 -- 99 69
52 Week -- -- -- 46
YTD -- -- -- 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 87.43%
# of Holders: 20
Total Shares Held: 34,800,638
3 Mo. Net Change: 989,223
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 9
# Reduced Positions: 3
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.